Pmv Net Debt vs Non Current Liabilities Total Analysis
PMVP Stock | USD 1.99 0.12 6.42% |
Pmv PharmaceuticalsI financial indicator trend analysis is much more than just breaking down Pmv PharmaceuticalsInc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pmv PharmaceuticalsInc is a good investment. Please check the relationship between Pmv PharmaceuticalsI Net Debt and its Non Current Liabilities Total accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Net Debt vs Non Current Liabilities Total
Net Debt vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pmv PharmaceuticalsInc Net Debt account and Non Current Liabilities Total. At this time, the significance of the direction appears to have strong relationship.
The correlation between Pmv PharmaceuticalsI's Net Debt and Non Current Liabilities Total is 0.68. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Pmv PharmaceuticalsInc, assuming nothing else is changed. The correlation between historical values of Pmv PharmaceuticalsI's Net Debt and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Pmv PharmaceuticalsInc are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Net Debt i.e., Pmv PharmaceuticalsI's Net Debt and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.68 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Non Current Liabilities Total
Most indicators from Pmv PharmaceuticalsI's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pmv PharmaceuticalsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At this time, Pmv PharmaceuticalsI's Tax Provision is relatively stable compared to the past year. As of 05/03/2024, Issuance Of Capital Stock is likely to grow to about 52.1 M, while Selling General Administrative is likely to drop slightly above 23 K.
2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 449K | 3.6M | 9.8M | 10.3M | Net Interest Income | 449K | 3.6M | 9.8M | 10.3M |
Pmv PharmaceuticalsI fundamental ratios Correlations
Click cells to compare fundamentals
Pmv PharmaceuticalsI Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pmv PharmaceuticalsI fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 103.0M | 365.5M | 331.6M | 270.3M | 252.2M | 254.1M | |
Other Current Liab | 1.7M | 4.8M | 8.6M | 7.3M | 9.9M | 6.2M | |
Total Current Liabilities | 4.5M | 6.4M | 12.2M | 10.8M | 14.0M | 9.2M | |
Total Stockholder Equity | (70.5M) | 359.1M | 308.6M | 246.0M | 225.7M | 187.5M | |
Net Tangible Assets | (70.5M) | 359.1M | 308.6M | 246.0M | 282.9M | 175.4M | |
Property Plant And Equipment Net | 739K | 569K | 13.2M | 20.5M | 19.0M | 10.1M | |
Net Debt | 95.7M | (361.4M) | (161.3M) | (94.3M) | (25.2M) | (26.5M) | |
Retained Earnings | (75.4M) | (109.9M) | (167.7M) | (241.0M) | (310.0M) | (294.5M) | |
Accounts Payable | 2.8M | 1.6M | 3.2M | 3.0M | 3.2M | 2.7M | |
Cash | 73.3M | 361.4M | 172.5M | 108.3M | 38.5M | 36.6M | |
Non Current Assets Total | 940K | 770K | 30.3M | 23.3M | 44.7M | 47.0M | |
Cash And Short Term Investments | 101.5M | 361.4M | 297.2M | 241.1M | 203.9M | 232.3M | |
Common Stock Shares Outstanding | 43.0M | 44.8M | 45.1M | 45.6M | 48.0M | 47.3M | |
Short Term Investments | 28.2M | 0.0 | 124.7M | 132.8M | 165.4M | 88.5M | |
Liabilities And Stockholders Equity | 103.0M | 365.5M | 331.6M | 270.3M | 252.2M | 254.1M | |
Non Current Liabilities Total | 169.0M | 1.6M | 10.8M | 13.4M | 12.4M | 11.8M | |
Other Current Assets | 607K | 3.3M | 3.3M | 5.1M | 3.5M | 3.0M | |
Other Stockholder Equity | 4.8M | 103.5M | 476.4M | 487.5M | 535.5M | 295.5M | |
Total Liab | 173.5M | 6.4M | 23.0M | 24.3M | 26.5M | 48.4M | |
Net Invested Capital | (70.5M) | 359.1M | 308.6M | 246.0M | 225.7M | 187.5M | |
Property Plant And Equipment Gross | 739K | 569K | 13.2M | 20.5M | 22.3M | 23.4M | |
Total Current Assets | 102.1M | 364.8M | 301.3M | 247.0M | 207.4M | 235.5M | |
Net Working Capital | 97.6M | 358.4M | 289.1M | 236.2M | 193.4M | 226.3M | |
Property Plant Equipment | 739K | 569K | 13.2M | 11.0M | 12.6M | 13.2M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pmv PharmaceuticalsInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Pmv Stock analysis
When running Pmv PharmaceuticalsI's price analysis, check to measure Pmv PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv PharmaceuticalsI is operating at the current time. Most of Pmv PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Pmv PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Pmv PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
CEOs Directory Screen CEOs from public companies around the world |
Is Pmv PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv PharmaceuticalsI. If investors know Pmv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Pmv PharmaceuticalsInc is measured differently than its book value, which is the value of Pmv that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Pmv PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Pmv PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pmv PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.